Muscular Atrophy, Spinal D009134

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Spinal Cord Diseases » Muscular Atrophy, Spinal

Diseases [C] » Nervous System Diseases [C10] » Neurodegenerative Diseases » Motor Neuron Disease » Muscular Atrophy, Spinal

Diseases [C] » Nervous System Diseases [C10] » Neuromuscular Diseases » Motor Neuron Disease » Muscular Atrophy, Spinal

Description

A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)   MeSH

Hierarchy View

Subtype Terms (2)

Bulbo-Spinal Atrophy, X-Linked
5 drugs (4 approved, 1 experimental)

Spinal Muscular Atrophies of Childhood
9 drugs (5 approved, 4 experimental)


Approved Indicated Drugs (1)

Phase 4 Indicated Drugs (2)

Other Experimental Indicated Drugs (1)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 1 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.